
Opinion: The Trump administration should rescind the NIH ‘access planning’ rule
At the start of the year, the National Institutes of Health finalized a policy that will require anyone seeking to license certain NIH-owned patents to submit an “access plan” detailing how they plan to make their products available to underserved groups. …